Burns brings over 25 years experience in the Biopharmaceuticals and Biotechnology industry, having held a series of leadership roles including CEO and Founder of SweetSpot Therapeutics. Evetts joins with over 20 years experience in the Pharmaceutical industry. He has a track record of senior strategic and operational roles including Business Development and Portfolio Director at AstraZeneca.